Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications

IF 9.1 1区 医学 Q1 ONCOLOGY
Ludi Yang , Sipeng Zuo , Ruobing Jia , Xiang Gu , Qili Liao , Yu Hua , Shengfang Ge , Mengjia He , Jiayan Fan , Xuemei Tong , Tifei Yuan , Renbing Jia , Xianqun Fan , Peiwei Chai , Xuyang Wen
{"title":"Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications","authors":"Ludi Yang ,&nbsp;Sipeng Zuo ,&nbsp;Ruobing Jia ,&nbsp;Xiang Gu ,&nbsp;Qili Liao ,&nbsp;Yu Hua ,&nbsp;Shengfang Ge ,&nbsp;Mengjia He ,&nbsp;Jiayan Fan ,&nbsp;Xuemei Tong ,&nbsp;Tifei Yuan ,&nbsp;Renbing Jia ,&nbsp;Xianqun Fan ,&nbsp;Peiwei Chai ,&nbsp;Xuyang Wen","doi":"10.1016/j.canlet.2025.217804","DOIUrl":null,"url":null,"abstract":"<div><div>The perturbation of histone modification homeostasis is a hallmark of oncogene activation and tumor suppressor gene silencing. Howbeit, the intricate interplay among diverse histone modifications in the context of tumorigenesis is not fully understood. Herein, we unveil a positive feedback mechanism involving lactylation and methylation of histones, which is instrumental in the oncogenic progression of retinoblastoma. First, we pinpointed that the selective upregulation of SUZ12 leads to the upregulation of H3K27me3 modification in retinoblastoma, which is attributed to heightened levels of histone lactylation. Notably, the targeted suppression of <em>SUZ12</em> has demonstrated significant therapeutic benefits in both <em>in vitro</em> and <em>in vivo</em> models of retinoblastoma. Furthermore, multi-omics analysis has identified Krüppel-like factor 4 (<em>KLF4</em>) as a key downstream effector of SUZ12. Mechanistically, SUZ12 is implicated in the enhancement of the H3K27me3 mark on the <em>KLF4</em> promoter, thereby repressing its transcription. Intriguingly, the downregulation of <em>KLF4</em> is associated with an upregulation of glycolysis and a concomitant accumulation of the onco-metabolite lactate, which in turn augments histone lactylation. In conclusion, we provide novel insights into the intricate interplay between lactylation and methylation of histones, shedding light on the epigenetic-metabolic reprogramming that underlies oncogene activation and tumor suppressor gene inactivation in cancer.</div></div>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"625 ","pages":"Article 217804"},"PeriodicalIF":9.1000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383525003714","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The perturbation of histone modification homeostasis is a hallmark of oncogene activation and tumor suppressor gene silencing. Howbeit, the intricate interplay among diverse histone modifications in the context of tumorigenesis is not fully understood. Herein, we unveil a positive feedback mechanism involving lactylation and methylation of histones, which is instrumental in the oncogenic progression of retinoblastoma. First, we pinpointed that the selective upregulation of SUZ12 leads to the upregulation of H3K27me3 modification in retinoblastoma, which is attributed to heightened levels of histone lactylation. Notably, the targeted suppression of SUZ12 has demonstrated significant therapeutic benefits in both in vitro and in vivo models of retinoblastoma. Furthermore, multi-omics analysis has identified Krüppel-like factor 4 (KLF4) as a key downstream effector of SUZ12. Mechanistically, SUZ12 is implicated in the enhancement of the H3K27me3 mark on the KLF4 promoter, thereby repressing its transcription. Intriguingly, the downregulation of KLF4 is associated with an upregulation of glycolysis and a concomitant accumulation of the onco-metabolite lactate, which in turn augments histone lactylation. In conclusion, we provide novel insights into the intricate interplay between lactylation and methylation of histones, shedding light on the epigenetic-metabolic reprogramming that underlies oncogene activation and tumor suppressor gene inactivation in cancer.
乳酸化促进的KLF4多梳抑制引发视网膜母细胞瘤中的糖酵解:组蛋白修饰之间的正反馈回路
组蛋白修饰内稳态的扰动是癌基因激活和肿瘤抑制基因沉默的标志。然而,在肿瘤发生的背景下,不同组蛋白修饰之间复杂的相互作用尚未完全了解。在此,我们揭示了一种涉及组蛋白乳酸化和甲基化的正反馈机制,这有助于视网膜母细胞瘤的癌性进展。首先,我们确定了SUZ12的选择性上调导致视网膜母细胞瘤中H3K27me3修饰上调,这是由于组蛋白乳酸化水平升高。值得注意的是,在视网膜母细胞瘤的体外和体内模型中,靶向抑制SUZ12已显示出显著的治疗效果。此外,多组学分析发现kr ppel样因子4 (KLF4)是SUZ12的关键下游效应因子。从机制上讲,SUZ12与KLF4启动子上H3K27me3标记的增强有关,从而抑制其转录。有趣的是,KLF4的下调与糖酵解的上调和伴随的肿瘤代谢物乳酸的积累有关,这反过来又增加了组蛋白的乳酸化。总之,我们为组蛋白的乳酸化和甲基化之间复杂的相互作用提供了新的见解,揭示了癌症中致癌基因激活和肿瘤抑制基因失活的表观遗传代谢重编程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer letters
Cancer letters 医学-肿瘤学
CiteScore
17.70
自引率
2.10%
发文量
427
审稿时长
15 days
期刊介绍: Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research. Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy. By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信